Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 28, 16:00
2604.85
11.55 (0.45%)
VOLUME 13,748
LIVE
NSE
Apr 28, 16:44
2599.15
2.6 (0.1%)
VOLUME 136,374
News on Dr Reddys Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's gets 11 observations from USFDA for Hyderabad plant

9.08 pm | 28 Apr 2017 |  Source: PTI

Drug major Dr Reddy’s Laboratories today said the US health regulator has issued 11 observations after inspecting its manufacturing plant in Hyderab...

Dr Reddy's launches cholesterol-lowering generic pill Vytorin in US

3.38 pm | 27 Apr 2017 |  Source: Moneycontrol.com

The Vytorin brand had US sales of approximately USD 678 million for the most recent 12 months ended in February 2017, according to IMS Health....

Dr Reddy's Laboratories launches Ezetimibe and Simvastatin tablets in US market

10.27 am | 27 Apr 2017 |  Source: Moneycontrol.com

Dr Reddy's Laboratories has launched Ezetimibe and Simvastatin Tablets, 10mg/10mg, 10mg/20mg, 10mg/40mg, and 10mg/80mg, a therapeutic equivalent g...

USFDA observations for Dr Reddy's Srikakulam plant merely procedural 

10.14 pm | 25 Apr 2017 |  Source: CNBC-TV18

CNBC-TV18 accessed the form 483 which includes the two observations. While the first observation says that the pharma major's Srikakulam lab recor...

Dr Reddy’s Laboratories to announce Q4 results on May 12, 2017

2.40 pm | 25 Apr 2017 |  Source: Moneycontrol.com

Dr Reddy’s Laboratories will announce results for the fourth quarter and full year ended March 31, 2017 on May 12, 2017 after the board meeting....

Dr Reddy's launches generic Progesterone capsules in US

7.53 pm | 21 Apr 2017 |  Source: PTI

Drug firm Dr Reddy's today said it has launched generic Progesterone capsules used in treatment of menstrual irregularities and protection of the ...

Dr. Reddy’s Q4 PAT seen up 6.3% to Rs 499.9 cr: ICICI Securities

1.24 pm | 17 Apr 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 2.5 percent Q-o-Q (up 1.2 percent Y-o-Y) to Rs 3800.9 crore, according to ICICI Securities. Dr. Reddy’s to rep...

Dr Reddy's Lab gains 3% on ‘no observations’ from USFDA for Srikakulam plant

9.47 am | 17 Apr 2017 |  Source: Moneycontrol.com

The USFDA audit was conducted at its active pharmaceutical ingredient (API) Srikakulam special economic zone plant, from April 10-14....

Stocks in the news: IOC, Cipla, Nestle, Indian Hume Pipe, Reliance Power

8.11 am | 17 Apr 2017 |  Source: CNBC-TV18

IOC | Cipla | Nestle | Indian Hume Pipe | Reliance Power are stocks, which are in news today....

Dr Reddy's clears US FDA audit at API plant in SEZ, Srikakulam 

12.13 pm | 15 Apr 2017 |  Source: Moneycontrol.com

The US FDA audit was conducted at its active pharmaceutical ingredient (API) Srikakulam special economic zone plant, from April 10 – 14....

Dr Reddy's recalls 1,728 bottles of dementia drug from US

3.52 pm | 13 Apr 2017 |  Source: PTI

The company's US arm, Dr Reddy's Laboratories Inc is recalling Rivastigmine Tartrate capsules 1.5 mg in 60-count bottle manufactured by Dr Red...

Hold Dr. Reddy's Laboratories; target of Rs 2620: Edelweiss

1.39 pm | 13 Apr 2017 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Dr. Reddy's Laboratories with a target price of Rs 2620 in its research report dated April 12, 2017....

Dr Reddy's gets two USFDA observations for Srikakulam plant 

8.30 pm | 04 Apr 2017 |  Source: Moneycontrol.com

The company said was addressing the observations raised by US FDA without specifying the nature of those observations....

Check out: Top 5 largecap stocks which failed to deliver in FY2017

1.14 pm | 01 Apr 2017 |  Source: Moneycontrol.com

Moneycontrol takes a look at 5 stocks which failed to deliver during the last fiscal. If you continue to hold it your portfolio, here's how you ca...

Dr Reddy's to market Integra LifeSciences products in India

3.45 pm | 27 Mar 2017 |  Source: PTI

Under the agreement, Dr Reddy's will market and distribute DuraGen Plus and Suturable DuraGen dural regeneration matrices for use in patients in t...

Dr Reddy's Laboratories enters into agreement with Integra Life

12.52 pm | 27 Mar 2017 |  Source: Moneycontrol.com

Dr. Reddy's and Integra LifeSciences enter into an agreement to market and distribute DuraGen Plus and Suturable DuraGen Dural Regeneration in India....

US regulator set to begin inspection of Dr Reddy's Srikakulam unit on March 27 

3.50 pm | 24 Mar 2017 |  Source: CNBC-TV18

Dr. Reddy’s said it spent about $35-40 million on remediation work that includes legal and professional charges....

Sell Dr Reddy’s Laboratories, Axis Bank, Bharat Forge, TVS Motor; buy ICICI Bank: Sudarshan Sukhani 

10.38 am | 23 Mar 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends selling Dr Reddy’s Laboratories, Axis Bank, Bharat Forge and TVS Motor and advises buying ICICI Ban...

Sell Dr Reddy's Laboratories on bounce: Sandeep Wagle 

3.44 pm | 22 Mar 2017 |  Source: CNBC-TV18

According to Sandeep Wagle of powermywealth.com, one may sell Dr Reddy's Laboratories on bounce back towards Rs 2,700-2,750....

Exit Dr Reddy's Laboratories: Shahina Mukadam 

3.44 pm | 22 Mar 2017 |  Source: CNBC-TV18

Shahina Mukadam, Independent Market Expert advises exiting Dr Reddy's Laboratories....

1 2 3 4 5 6 7
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.